Logo image of EYES

SECOND SIGHT MEDICAL PRODUCT (EYES) Stock Analyst Ratings

USA - NASDAQ:EYES - US81362J3086 - Common Stock

4.14 USD
-0.22 (-5.05%)
Last: 8/30/2022, 8:10:00 PM
4.0921 USD
-0.05 (-1.16%)
After Hours: 8/30/2022, 8:10:00 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to EYES. The Buy consensus is the weighted average rating of the current analysts ratings.

EYES was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about EYES.
In the previous month the buy percentage consensus was at a similar level.
EYES was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

EYES Historical Analyst RatingsEYES Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -46 -42 -38 -34 -30 -26 -22 -18 -14 -10 -6 -2 2 4 6

Related screens

EYES Current Analyst RatingEYES Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

SECOND SIGHT MEDICAL PRODUCT / EYES FAQ

How do analysts rate SECOND SIGHT MEDICAL PRODUCT (EYES)?

The consensus rating for SECOND SIGHT MEDICAL PRODUCT (EYES) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.